These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 11071333)

  • 21. [Results of different postoperative adjuvant therapies for stage Ib-IIa cervical carcinoma with risk factors].
    Wen HW; Huang WP; Liu TY; Ma K; Tao X; Zhu LR; Liao QP
    Zhonghua Fu Chan Ke Za Zhi; 2013 Dec; 48(12):920-4. PubMed ID: 24495686
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cancer of the cervix stage Ib and IIa: survival related to treatment and histopathological risk factors.
    Ngan HY; Obradovic D; Krauer F
    Eur J Surg Oncol; 1988 Jun; 14(3):203-8. PubMed ID: 3371471
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cyclooxygenase-2 expression in squamous cell carcinoma of the uterine cervix is associated with lymph node metastasis.
    Khunamornpong S; Settakorn J; Sukpan K; Srisomboon J; Ruangvejvorachai P; Thorner PS; Siriaunkgul S
    Gynecol Oncol; 2009 Jan; 112(1):241-7. PubMed ID: 18977022
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term follow-up of stage I cervical adenocarcinoma treated by radical surgery.
    McLellan R; Dillon MB; Woodruff JD; Heatley GJ; Fields AL; Rosenshein NB
    Gynecol Oncol; 1994 Feb; 52(2):253-9. PubMed ID: 8314148
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Postoperative adjuvant concurrent chemoradiotherapy improves survival rates for high-risk, early stage cervical cancer patients.
    Ryu HS; Chun M; Chang KH; Chang HJ; Lee JP
    Gynecol Oncol; 2005 Feb; 96(2):490-5. PubMed ID: 15661240
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adjuvant therapy after primary surgery for stage I-IIA carcinoma of the cervix.
    Thomas GM
    J Natl Cancer Inst Monogr; 1996; (21):77-83. PubMed ID: 9023833
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Histopathological factors influencing pelvic lymph node metastases in two or more sites in patients with cervical carcinoma undergoing radical hysterectomy.
    Kamura T; Shigematsu T; Kaku T; Shimamoto T; Saito T; Sakai K; Mitsumoto M; Nakano H
    Acta Obstet Gynecol Scand; 1999 May; 78(5):452-7. PubMed ID: 10326894
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Indication and efficacy of radiation therapy following radical surgery in patients with stage IB to IIB cervical cancer.
    Okada M; Kigawa J; Minagawa Y; Kanamori Y; Shimada M; Takahashi M; Oishi T; Terakawa N
    Gynecol Oncol; 1998 Jul; 70(1):61-4. PubMed ID: 9698475
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of lymphovascular invasion in predicting the prognosis of clinically localized upper tract urothelial carcinoma (pT1-3cN0M0).
    Lin WC; Hu FC; Chung SD; Chueh SC; Pu YS; Huang KH
    J Urol; 2008 Sep; 180(3):879-84; discussion 884-5. PubMed ID: 18635224
    [TBL] [Abstract][Full Text] [Related]  

  • 30. How important is removal of the parametrium at surgery for carcinoma of the cervix?
    Covens A; Rosen B; Murphy J; Laframboise S; DePetrillo AD; Lickrish G; Colgan T; Chapman W; Shaw P
    Gynecol Oncol; 2002 Jan; 84(1):145-9. PubMed ID: 11748991
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic factors in surgically treated stage ib-iib cervical carcinomas with special emphasis on the importance of tumor volume.
    Trattner M; Graf AH; Lax S; Forstner R; Dandachi N; Haas J; Pickel H; Reich O; Staudach A; Winter R
    Gynecol Oncol; 2001 Jul; 82(1):11-6. PubMed ID: 11426955
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multivariate analysis of the prognostic factors and outcomes in early cervical cancer patients undergoing radical hysterectomy.
    Ho CM; Chien TY; Huang SH; Wu CJ; Shih BY; Chang SC
    Gynecol Oncol; 2004 May; 93(2):458-64. PubMed ID: 15099962
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic factors in patients with with locally advanced cervical cancer treated with radical hysterectomy and adjuvant radiotherapy.
    Frigerio L; Mariani A; Gandini L; Origoni M; Galli L; Rabaiotti E; Aletti G; Ferrari A
    Int Surg; 1998; 83(3):265-70. PubMed ID: 9870789
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A multivariate analysis of blood vessel and lymph vessel invasion as predictors of ovarian and lymph node metastases in patients with cervical carcinoma.
    Sakuragi N; Takeda N; Hareyama H; Fujimoto T; Todo Y; Okamoto K; Takeda M; Wada Si; Yamamoto R; Fujimoto S
    Cancer; 2000 Jun; 88(11):2578-83. PubMed ID: 10861436
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of a T0 radical hysterectomy specimen on survival for early stage cervical cancer.
    Wright JD; Grigsby PW; Rader JS; Mutch DG; Powell MA; Gao F; Gibb RK
    Gynecol Oncol; 2007 Nov; 107(2):280-4. PubMed ID: 17698175
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Pelvic lymphadenectomy as an alternative to adjuvant radiotherapy in early stage endometrial cancer at high risk of recurrent lymphatic metastases (stage I)].
    Amato NA; Partipilo V; Mele F; Boscia F; De Marzo P
    Minerva Ginecol; 2009 Feb; 61(1):1-12. PubMed ID: 19204656
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stage I cervical adenocarcinoma: prognostic evaluation of surgically treated patients.
    Matthews CM; Burke TW; Tornos C; Eifel PJ; Atkinson EN; Stringer CA; Morris M; Silva EG
    Gynecol Oncol; 1993 Apr; 49(1):19-23. PubMed ID: 8482554
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Wertheim-operation: 5-year survival of 501 consecutive patients with cervical cancer].
    Papp Z; Csapó Z; Mayer A; Hupuczi P
    Orv Hetil; 2006 Mar; 147(12):537-45. PubMed ID: 16696377
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Surgically defined prognostic parameters in patients with early cervical carcinoma. A multivariate survival tree analysis.
    Sevin BU; Lu Y; Bloch DA; Nadji M; Koechli OR; Averette HE
    Cancer; 1996 Oct; 78(7):1438-46. PubMed ID: 8839549
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Early cervical cancer and parametrial involvement: is it significant?
    Steed H; Capstick V; Schepansky A; Honore L; Hiltz M; Faught W
    Gynecol Oncol; 2006 Oct; 103(1):53-7. PubMed ID: 16516279
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.